Related by context. Frequent words. (Click for all words.) 88 primary efficacy endpoint 83 primary endpoints 83 secondary endpoint 80 secondary endpoints 70 non inferiority 64 demonstrated statistically significant 64 statistical significance 64 statistically significant improvement 63 statistically significant reduction 63 evaluable patients 62 placebo 61 tolerability 61 clinically meaningful 61 evaluable 61 mg dose 60 placebo controlled 60 free survival PFS 60 p = #.# [002] 58 sunitinib 58 monotherapy 57 statistically significant 57 pharmacodynamic 57 randomized double 56 p = #.# [004] 56 double blind placebo 56 randomized controlled 56 Phase IIb clinical 56 randomized placebo controlled 55 docetaxel 55 randomized 55 p = 55 clinically relevant 55 Phase IIa 55 mg kg 55 pharmacokinetic profile 54 pegylated interferon 54 disease progression 54 HbA1c 54 Phase 1b 54 post hoc 54 dose escalation 54 efficacy 54 pharmacokinetic 54 picoplatin 53 HCV RNA 53 tolerability profile 53 Phase III clinical 53 Phase 2b 53 n = 53 safety tolerability 53 prospective randomized 53 infliximab 53 dosing regimen 53 bortezomib 53 randomization 53 ADX# 53 imatinib 53 pharmacokinetics 52 endpoints 52 viral load 52 sorafenib 52 pivotal Phase III 52 dosing 52 blind randomized placebo 52 rivaroxaban 52 bevacizumab 52 TAXUS 52 pivotal Phase 52 randomized clinical 52 Phase 2a 52 blind placebo controlled 52 Phase IIb 52 RG# [001] 52 blind randomized 51 multicenter 51 copies mL 51 Zenvia 51 FOLOTYN 51 endpoint 51 clinical trial 51 gemcitabine 51 belimumab 51 Phase IIb trial 51 erlotinib 50 statistically significant differences 50 tumor shrinkage 50 Prochymal 50 ≥ 50 bone metastases 50 FEV1 50 Phase III 50 trastuzumab 50 everolimus 50 zoledronic acid 50 CK # 50 proteinuria 50 Vectibix 49 hormone refractory prostate cancer 49 dexamethasone 49 renal function 49 mg/m2